Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

Bibliographic Details
Main Authors: van Vollenhoven, Ronald F, Petri, Michelle A, Cervera, Ricard, Roth, David A, Ji, Beulah N, Kleoudis, Christi S, Zhong, Z John, Freimuth, William
Format: Online
Language:English
Published: BMJ Group 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396451/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396451/

Similar Items